Understanding Diabetic Foot Infection and its Management

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 11, Issue 2, 2017, Pages 149-156

  Noor, Saba ^a   Khan, Rizwan Ullah ^b   Ahmad, Jamal ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b Integral Institute of Medical Sciences and Research   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BONE INFECTION; CLINICAL EVALUATION; DIABETIC FOOT; DISEASE CLASSIFICATION; DISEASE SEVERITY; FOOT; HUMAN; IMMUNOPATHOLOGY; LABORATORY TEST; MANAGED CARE; MICROBIOLOGY; NEUROPATHY; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; COMPLICATION; INFECTION; SEVERITY OF ILLNESS INDEX;

DIABETIC FOOT; HUMANS; INFECTION; SEVERITY OF ILLNESS INDEX;

EID: 85003782000     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2016.06.023     Document Type: Review

References (50)

1. [1] Singh, N., Armstrong, D.G., Lipsky, B.A., Preventing foot ulcers in patients with diabetes. JAMA 293 (2005), 217–228.
2. [2] National diabetes fact sheet, 2011. US Department of Health and Human Services. Center for Disease Control and Prevention, Atlanta, GA (2011).
3. [3] Prompers, L., Huijberts, M., Apelqvist, J., et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia 50 (2007), 18–25.
4. [4] International Working Group on the Diabetic Foot, International consensus on the diabetic foot, Amsterdam (1999) 1–96.
5. [5] Pecoraro, R.E., Ahroni, J.H., Boyko, E.J., Stencil, V.L., Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 40 (1991), 1305–1313.
6. [6] Reiber, G.E., Pecoraro, R.E., Koepsell, T.D., Risk factors for amputation in patients with diabetes mellitus: a case control study. Ann Intern Med 117 (1992), 97–105.
7. [7] van Battum, P., Schaper, N., Prompers, L., Apelqvist, J., Jude, E., Piaggesi, A., Differences in minor amputation rate in diabetic foot disease throughout Europe are in part explained by differences in disease severity at presentation. Diabet Med, 28, 2011, 199205.
8. [8] Armstrong, D.G., Lavery, L.A., Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Phys 57 (1998), 1325–1332.
9. [9] Reiber, G.E., Vileikyte, L., Boyko, E.J., del Aguila, M., Smith, D.G., Lavery, L.A., Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care 22 (1999), 157–162.
10. [10] Noor, S., Zubair, M., Ahmad, J., Diabetic foot ulcer–a review on pathophysiology, classification and microbial etiology. Diabetes Metab Syndr 9 (2015), 192–199.
11. [11] Ahmad, J., The diabetic foot. Diabetes Metab Syndr: Clin Res Rev 10 (2016), 48–60.
12. [12] McNeely, M.J., Boyko, E.J., Ahroni, J.H., Stensel, V.L., Reiber, G.E., Smith, D.G., et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?. Diabetes Care 18 (1995), 216–219.
13. [13] Noor, S., Ahmad, J., Parwez, I., A pilot study on co-relation between inflammatory markers with Ankle brachial index in patients with type 2 diabetes in North Indian Population. IJNTR 3 (2016), 143–147.
14. [14] Hobizal, K.B., Wukich, D.K., Diabetic foot infections: current concept review. Diabet Foot Ankle, 3, 2012, 18409.
15. [15] Pecoraro, R.E., Ahroni, J.H., Boyko, E.J., Stensel, V.L., Chronology and determinants of tissue repair in diabetic lower-extremity ulcers. Diabetes 40 (1991), 1305–1313.
16. [16] Mars, M., Transcutaneous oxygen tension as a predictor of success after an amputation. J Bone Joint Surg Am 70 (1988), 1429–1430.
17. [17] Bridges, R.M. Jr., Deitch, E.A., Diabetic foot infections: path physiology and treatment. Surg Clin North Am 74 (1994), 537–555.
18. [18] Hostetter, M.K., Perspectives in diabetes. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 39 (1990), 271–275.
19. [19] Geerlings, S.E., Brouwer, E.C., Gaastra, W., Verhoef, J., Hoepelman, A.I.M., The effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: Studies using urine from diabetics and non-diabetics. J Med Microbiol 48 (1999), 535–539.
20. [20] Deresinski, S., Infections in the diabetic patient: strategies for the clinician. Infect Dis Rep 1 (1995), 1–12.
21. [21] Sentochnik, D.E., Eliopoulos, G.M., Infection and diabetes. Kahn, C.R., Weir, G.C., (eds.) Joslin's diabetes mellitus, 13th ed., 1994, Lea & Febiger, Philadelphia, 867–868.
22. [22] Keidar, Z., Militianu, D., Melamed, E., Bar-Shalom, R., Israel, O., The diabetic foot: initial experience with 18F-FDG PET/CT. J Nucl Med, 46, 2005 444-9.1.
23. [23] Basu, S., Chryssikos, T., Houseni, M., et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft tissue infection. Nucl Med Commun 28 (2007), 465–472.
24. [24] Lavery, L.A., Armstrong, D.G., Wunderlich, R.P., Mohler, M.J., Wendel, C.S., Lipsky, B.A., Risk factors for foot infections in individuals with diabetes. Diabetes Care, 29, 2006, 128893.
25. [25] Lipsky, B.A., Peters, E.J., Berendt, A.R., Senneville, E., Bakker, K., Embil, J.M., et al. International Working Group on Diabetic Foot: specific guidelines for the treatment of diabetic foot infections. Diabetes Metab Res Rev 2012:28 Suppl. (1) (2011), 234–235.
26. [26] American Diabetes Association, Peripheral arterial disease in people with diabetes. Diabetes Care 26 (2003), 3333–3341.
27. [27] Boulton, A.J., Armstrong, D.G., Albert, S.F., et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 31 (2008), 1679–1685.
28. [28] Edwards, R., Harding, K.G., Bacteria and wound healing. Curr Opin Infect Dis 17 (2004), 91–96.
29. [29] Abbas, Z.G., Lutale, J.K., Ilondo, M.M., Archibald, L.K., The utility of Gram stains and culture in the management of limb ulcers in persons with diabetes. Int Wound J 9 (2012), 677–682.
30. [30] Gadepalli, R., Dhawan, B., Sreenivas, V., Kapil, A., Ammini, A.C., Chaudhry, R., A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care 29 (2006), 1727–1732.
31. [31] Zubair, M., Abida, M., Jamal, A., Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary hospital. Foot 22 (2011), 24–30.
32. [32] Dang, C.N., Prasad, Y.D., Boulton, A.J., Jude, E.B., Methicillin-resistant Staphylococcus aureus in the diabetic foot clinic: a worsening problem. Diabet Med 20 (2003), 159–161.
33. [33] Zubair, M., Malik, A., Ahmad, J., Study of plasmid-mediated extended-spectrum beta-lactamase-producing strains of enterobacteriaceae, isolated from diabetic foot infections in a North Indian tertiary-care hospital. Diabet Technol Ther 14 (2012), 315–324.
34. [34] Tascini, C., Gemignani, G., Palumbo, F., Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without Osteomyelitis. J Chemother 18 (2006), 648–651.
35. [35] Zubair, M., Malik, A., Ahmad, J., Prevalence of metallo-ß- lactamase-producing Pseudomonas aeruginosa isolated from diabetic foot ulcer patients. Diabetes Metab Syndr 5 (2011), 90–92.
36. [36] Kandemir, O., Akbay, E., Sahin, E., Milcan, A., Gen, R., Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms. J Infect 54 (2007), 439–445.
37. [37] Wagner, F.W. Jr., The dysvascular foot: a system for diagnosis and treatment. Foot Ankle, 2, 1981, 64122.
38. [38] Oyibo, S.O., Jude, E.B., Tarawneh, I., Nguyen, H.C., Harkless, L.B., Boulton, A.J., A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care, 24, 2001, 848.
39. [39] Lavery, L.A., Armstrong, D.G., Murdoch, D.P., Peters, E.J., Lipsky, B.A., Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis, 44, 2007, 5625.
40. [40] Lipsky, B.A., Peters, E.J., Senneville, E., Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev 28:Suppl. (1) (2012), 163–178.
41. [41] Marvaso, A., Esposito, S., Noviello, S., Outpatient parenteral antibiotic therapy (OPAT) of diabetic foot infections with piperacillin/tazobactam. Infez Med. 10 (2002), 230–235.
42. [42] Lipsky, B.A., Berendt, A.R., Deery, H.G., Embil, J.M., Joseph, W.S., Karchmer, A.W., et al. Infectious Diseases Society of America: diagnosis and treatment of diabetic foot infections. Clin Infect Dis 39 (2004), 885–910.
43. [43] Lipsky, B.A., Aragón-Sánchez, J., Diggle, M., et al. IWGDF Guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev, 2015.
44. [44] Tan, J.S., Friedman, N.M., Hazelton-Miller, C., Flanagan, J.P., File, T.M.J., Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation. Clin Infect Dis 23 (1996), 286–291.
45. [45] Hinchliffe, R.J., Valk, G.D., Apelqvist, J., A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev 24:Suppl. (1) (2008), S119–S144.
46. [46] Papanas, N., Eleftheriadou, I., Tentolouris, N., Maltezos, E., Advances in the topical treatment of diabetic foot ulcers. Curr Diabetes Rev 8 (2012), 209–218.
47. [47] Dorresteijn, J.A., Kriegsman, D.M., Assendelft, W.J., Valk, G.D., Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev, 2012 CD001488.
48. [48] Bengtsson, L., Jonsson, M., Apelqvist, J., Wound related pain is underestimated in patients with diabetic foot ulcers. J Wound Care 17:10 (2008), 433–435.
49. [49] Gary Sibbald, R., Woo, K.Y., The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab Res Rev 24:suppl. (1) (2008), S25–S30.
50. [50] Monteiro-Soares, M., Boyko, E.J., Ribeiro, J., Ribeiro, I., Dinis-Ribeiro, M., Risk stratification systems for diabetic foot ulcers: a systematic review. Diabetologia 54 (2011), 1190–1199.